Literature DB >> 29023320

Favorable liver cancer mortality-to-incidence ratios of countries with high health expenditure.

Chi-Chih Wang1, Ming-Chang Tsai, Cheng-Ming Peng, Hsiang-Lin Lee, Hsuan-Yi Chen, Tzu-Wei Yang, Wen-Wei Sung, Chun-Che Lin.   

Abstract

OBJECTIVE: Health expenditure is a marker associated with an advanced healthcare system, which contributes toward the good prognosis of patients. Mortality-to-incidence ratios (MIRs) are one of the predictors that reflect the prognosis of cancer patients. There remains some uncertainty on the correlation of MIRs of liver cancer with the health expenditure of countries.
METHODS: We therefore analyzed the correlation of MIRs from the GLOBOCAN 2012 database with the WHO rankings and the total expenditures on health/gross domestic product from WHO by linear regression analyses. A total of 29 countries were selected in this study according to the data quality and the incidence number.
RESULTS: The results showed high rates of incidence/mortality and MIRs in less developed regions (0.92 vs. 0.96 for more vs. less developed regions). Among the continents, Asia has the highest incidence/mortality in case number, crude rate, and age-standardized rate. In terms of the MIR, Northern America has the lowest MIR and Latin America and the Caribbean have the highest MIRs (0.82 and 1.04, respectively). Finally, favorable MIRs are associated significantly with good WHO ranking and high expenditures on gross domestic product (P=0.048 and 0.025, respectively).
CONCLUSION: The MIR variation for liver cancer is thus found to be associated with the health expenditure and WHO ranking.

Entities:  

Mesh:

Year:  2017        PMID: 29023320     DOI: 10.1097/MEG.0000000000000969

Source DB:  PubMed          Journal:  Eur J Gastroenterol Hepatol        ISSN: 0954-691X            Impact factor:   2.566


  5 in total

Review 1.  Association Between Spending and Outcomes for Patients With Cancer.

Authors:  Meng Li; Darius N Lakdawalla; Dana P Goldman
Journal:  J Clin Oncol       Date:  2019-12-05       Impact factor: 44.544

2.  Correlations between Mortality-to-Incidence Ratios and Health Care Disparities in Testicular Cancer.

Authors:  Wen-Jung Chen; Cheng-Yu Huang; Yu-Hui Huang; Shao-Chuan Wang; Tzuo-Yi Hsieh; Sung-Lang Chen; Wen-Wei Sung; Tsung-Hsien Lee
Journal:  Int J Environ Res Public Health       Date:  2019-12-23       Impact factor: 3.390

3.  Trends in the kidney cancer mortality-to-incidence ratios according to health care expenditures of 56 countries.

Authors:  Wen-Wei Sung; Po-Yun Ko; Wen-Jung Chen; Shao-Chuan Wang; Sung-Lang Chen
Journal:  Sci Rep       Date:  2021-01-14       Impact factor: 4.379

4.  Global pattern of trends in incidence, mortality, and mortality-to-incidence ratio rates related to liver cancer, 1990-2019: a longitudinal analysis based on the global burden of disease study.

Authors:  Maedeh Amini; Mehdi Azizmohammad Looha; Elaheh Zarean; Mohamad Amin Pourhoseingholi
Journal:  BMC Public Health       Date:  2022-03-29       Impact factor: 3.295

5.  Favorable mortality-to-incidence ratios of kidney Cancer are associated with advanced health care systems.

Authors:  Wen-Wei Sung; Shao-Chuan Wang; Tzuo-Yi Hsieh; Cheng-Ju Ho; Cheng-Yu Huang; Yu-Lin Kao; Wen-Jung Chen; Sung-Lang Chen
Journal:  BMC Cancer       Date:  2018-08-06       Impact factor: 4.430

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.